151 related articles for article (PubMed ID: 15998939)
1. The use of soluble, salivary c-erbB-2 for the detection and post-operative follow-up of breast cancer in women: the results of a five-year translational research study.
Streckfus C; Bigler L
Adv Dent Res; 2005 Jun; 18(1):17-24. PubMed ID: 15998939
[TBL] [Abstract][Full Text] [Related]
2. Methods for analyzing saliva proteins for systemic disease detection.
Luther T; Carrion CF; Cobb N; Le G; Edwards C; Schwartz S; Streckfus C
Gen Dent; 2010; 58(2):110-3. PubMed ID: 20236918
[TBL] [Abstract][Full Text] [Related]
3. Salivary biomarkers for the detection of malignant tumors that are remote from the oral cavity.
Bigler LR; Streckfus CF; Dubinsky WP
Clin Lab Med; 2009 Mar; 29(1):71-85. PubMed ID: 19389552
[TBL] [Abstract][Full Text] [Related]
4. The potential use of saliva to detect recurrence of disease in women with breast carcinoma.
Bigler LR; Streckfus CF; Copeland L; Burns R; Dai X; Kuhn M; Martin P; Bigler SA
J Oral Pathol Med; 2002 Aug; 31(7):421-31. PubMed ID: 12165061
[TBL] [Abstract][Full Text] [Related]
5. CA 15-3 and c-erbB-2 presence in the saliva of women.
Streckfus C; Bigler L; Dellinger T; Pfeifer M; Rose A; Thigpen JT
Clin Oral Investig; 1999 Sep; 3(3):138-43. PubMed ID: 10803125
[TBL] [Abstract][Full Text] [Related]
6. The use of surface-enhanced laser desorption/ionization time-of-flight mass spectrometry to detect putative breast cancer markers in saliva: a feasibility study.
Streckfus CF; Bigler LR; Zwick M
J Oral Pathol Med; 2006 May; 35(5):292-300. PubMed ID: 16630293
[TBL] [Abstract][Full Text] [Related]
7. Reliability assessment of soluble c-erbB-2 concentrations in the saliva of healthy women and men.
Streckfus C; Bigler L; Dellinger T; Dai X; Cox WJ; McArthur A; Kingman A; Thigpen JT
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Feb; 91(2):174-9. PubMed ID: 11174594
[TBL] [Abstract][Full Text] [Related]
8. Saliva metabolomics opens door to biomarker discovery, disease diagnosis, and treatment.
Zhang A; Sun H; Wang X
Appl Biochem Biotechnol; 2012 Nov; 168(6):1718-27. PubMed ID: 22971835
[TBL] [Abstract][Full Text] [Related]
9. A preliminary study of CA15-3, c-erbB-2, epidermal growth factor receptor, cathepsin-D, and p53 in saliva among women with breast carcinoma.
Streckfus C; Bigler L; Tucci M; Thigpen JT
Cancer Invest; 2000; 18(2):101-9. PubMed ID: 10705871
[TBL] [Abstract][Full Text] [Related]
10. Salivary proteomics in biomedical research.
Zhang A; Sun H; Wang P; Wang X
Clin Chim Acta; 2013 Jan; 415():261-5. PubMed ID: 23146870
[TBL] [Abstract][Full Text] [Related]
11. The presence of soluble c-erbB-2 in saliva and serum among women with breast carcinoma: a preliminary study.
Streckfus C; Bigler L; Dellinger T; Dai X; Kingman A; Thigpen JT
Clin Cancer Res; 2000 Jun; 6(6):2363-70. PubMed ID: 10873088
[TBL] [Abstract][Full Text] [Related]
12. Proteomic identification of salivary transferrin as a biomarker for early detection of oral cancer.
Jou YJ; Lin CD; Lai CH; Chen CH; Kao JY; Chen SY; Tsai MH; Huang SH; Lin CW
Anal Chim Acta; 2010 Nov; 681(1-2):41-8. PubMed ID: 21035601
[TBL] [Abstract][Full Text] [Related]
13. Oral contraceptive usage and the expression of CA 15-3 and c-erbB-2 in the saliva of healthy women.
McIntyre R; Bigler L; Dellinger T; Pfeifer M; Mannery T; Streckfus C
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1999 Dec; 88(6):687-90. PubMed ID: 10625851
[TBL] [Abstract][Full Text] [Related]
14. The expression of the c-erbB-2 receptor protein in glandular salivary secretions.
Streckfus CF; Bigler L; Dellinger T; Kuhn M; Chouinard N; Dai X
J Oral Pathol Med; 2004 Nov; 33(10):595-600. PubMed ID: 15482325
[TBL] [Abstract][Full Text] [Related]
15. A computational method for prediction of saliva-secretory proteins and its application to identification of head and neck cancer biomarkers for salivary diagnosis.
Sun Y; Du W; Zhou C; Zhou Y; Cao Z; Tian Y; Wang Y
IEEE Trans Nanobioscience; 2015 Mar; 14(2):167-74. PubMed ID: 25675464
[TBL] [Abstract][Full Text] [Related]
16. The Oral Fluid MEMS/NEMS Chip (OFMNC): diagnostic and translational applications.
Li Y; Denny P; Ho CM; Montemagno C; Shi W; Qi F; Wu B; Wolinsky L; Wong DT
Adv Dent Res; 2005 Jun; 18(1):3-5. PubMed ID: 16000263
[TBL] [Abstract][Full Text] [Related]
17. Saliva proteome research: current status and future outlook.
Schulz BL; Cooper-White J; Punyadeera CK
Crit Rev Biotechnol; 2013 Sep; 33(3):246-59. PubMed ID: 22612344
[TBL] [Abstract][Full Text] [Related]
18. Salivary markers of systemic disease: noninvasive diagnosis of disease and monitoring of general health.
Lawrence HP
J Can Dent Assoc; 2002 Mar; 68(3):170-4. PubMed ID: 11911813
[TBL] [Abstract][Full Text] [Related]
19. Salivary protein/peptide profiling with SELDI-TOF-MS.
Schipper R; Loof A; de Groot J; Harthoorn L; van Heerde W; Dransfield E
Ann N Y Acad Sci; 2007 Mar; 1098():498-503. PubMed ID: 17435159
[TBL] [Abstract][Full Text] [Related]
20. Saliva analysis by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF-MS) in orthodontic treatment: first pilot study.
Ciavarella D; Mastrovincenzo M; D'Onofrio V; Chimenti C; Parziale V; Barbato E; Lo Muzio L
Prog Orthod; 2011 Nov; 12(2):126-31. PubMed ID: 22074837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
